Tepezza (teprotumumab)
pCPA File Number:
23170
Negotiation Status:
Under consideration for negotiation
Indication(s):
Thyroid Eye Disease
Sponsor/Manufacturer:
Amgen Canada Inc.
CDA-AMC Project Number:
SR0853-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable